glp 1 and glp 2 A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor GLP-1 & GLP-2

Expert-Led Care: Licensed medical providers guide your treatment

K.et al (2017)

In: Pharmacology and Physiology for Anesthesia , (Second Edition), eds

N, N-di(2-hydroxybenzyl) ethylenediamine-N,N-diacetic acid monohydrochloride (HBED) is also an iron chelator which binds to ferrous iron through the BBB, converting it to ferric iron and mitigating irons harm

A major real-world study published in early 2026 led by researchers at Johns Hopkins Bloomberg School of Public Health and analysing electronic health records from approximately 175,000 people with T1D in the US found that those taking GLP-1 drugs had a roughly 15% lower five-year risk of major cardiovascular events and a 19% lower risk of end-stage kidney disease, without any increase in hospitalisation for DKA or severe hypoglycemia